1. Home
  2. TGL vs CDT Comparison

TGL vs CDT Comparison

Compare TGL & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TGL
  • CDT
  • Stock Information
  • Founded
  • TGL 2020
  • CDT 2019
  • Country
  • TGL United States
  • CDT United States
  • Employees
  • TGL N/A
  • CDT N/A
  • Industry
  • TGL Retail: Computer Software & Peripheral Equipment
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TGL Technology
  • CDT Health Care
  • Exchange
  • TGL Nasdaq
  • CDT Nasdaq
  • Market Cap
  • TGL 4.1M
  • CDT 4.2M
  • IPO Year
  • TGL 2022
  • CDT N/A
  • Fundamental
  • Price
  • TGL $0.85
  • CDT $2.84
  • Analyst Decision
  • TGL
  • CDT
  • Analyst Count
  • TGL 0
  • CDT 0
  • Target Price
  • TGL N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • TGL 5.7M
  • CDT 655.2K
  • Earning Date
  • TGL 10-15-2025
  • CDT 11-14-2025
  • Dividend Yield
  • TGL N/A
  • CDT N/A
  • EPS Growth
  • TGL N/A
  • CDT N/A
  • EPS
  • TGL N/A
  • CDT N/A
  • Revenue
  • TGL $2,330,557.00
  • CDT N/A
  • Revenue This Year
  • TGL N/A
  • CDT N/A
  • Revenue Next Year
  • TGL N/A
  • CDT N/A
  • P/E Ratio
  • TGL N/A
  • CDT N/A
  • Revenue Growth
  • TGL N/A
  • CDT N/A
  • 52 Week Low
  • TGL $0.68
  • CDT $2.72
  • 52 Week High
  • TGL $39.00
  • CDT $2,198.40
  • Technical
  • Relative Strength Index (RSI)
  • TGL 44.91
  • CDT 57.41
  • Support Level
  • TGL $0.69
  • CDT $2.78
  • Resistance Level
  • TGL $1.17
  • CDT $3.22
  • Average True Range (ATR)
  • TGL 0.10
  • CDT 0.38
  • MACD
  • TGL -0.00
  • CDT -0.07
  • Stochastic Oscillator
  • TGL 33.98
  • CDT 6.74

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: